Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
absorption, alopecia, ancillary, anniversary, areata, arrangement, ASC, assumption, baricitinib, capsule, Codification, contractual, covalent, customer, distinct, dual, Eli, exclusively, fasted, fed, female, formulation, hybrid, interferon, ITK, iv, Lilly, linear, male, modification, predominant, Preliminary, previously, promised, quality, recognition, remote, separate, tablet, transaction, transient, ulcerative, volunteer
Removed:
design, enabling, NaN, payable, protect, teleworking, virtual
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view